Health Week at BPC Examining Pharmaceutical Patent Practices & Their Impact on Drug Prices
December 10, 2019 9-11:30 a.m. EST
Bipartisan Policy Center
1225 Eye Street NW, Suite 1000
Washington, D.C. xxxxxx Get Directions
While pharmaceutical patents and market exclusivity can incentivize innovation in the United States, various patent practices can also impact the affordability of brand drugs and biologics, especially for debilitating conditions such as rheumatoid arthritis, cancer, and diabetes. Please join us on Tuesday,
December 10, as BPC hosts a panel of experts to discuss the tactics used to delay competition through the patent system and the possible policy solutions to address this important issue.
Program
Fireside chat: Drew Hirshfeld, J.D. | Commissioner, United States Patent and Trademark Office
Markus Meier, J.D. | Assistant Director for Healthcare, Federal Trade Commission
Dr. Avik Roy| President, Foundation for Research on Equal Opportunity
Academic Panel discussion featuring: Michael Carrier, J.D. | Distinguished Professor, Rutgers Law School
Robin Feldman, J.D.| Arthur J. Goldberg Distinguished Professor of Law and Director of the Center for Innovation, University of California Hastings
Arti Rai, J.D. | Elvin R. Latty Professor of Law and Faculty Director, The Center for Innovation Policy, Duke University Law School
Melissa Wasserman, J.D. | Charles Tilford McCormick Professor of Law, University of Texas at Austin School of Law
Moderated by:
Dr. Anand Parekh | Chief Medical Advisor, Bipartisan Policy Center
